Antimicrobial resistance is one of the greatest challenges facing modern medicine. A new class of programmable antibiotics known as asobiotics can be used to treat bacterial infections when classical antibiotics fail. A team of researchers from TWINCORE, Centre for Experimental and Clinical Infection Research, the RESIST Cluster of Excellence and from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now studied, how bacteria adapt to asobiotics. They recently published their finding in Nature Communications. TWINCORE and HIRI are sites of the Helmholtz Centre for Infection Research (HZI) in cooperation with Hannover Medical School and Julius-Maximilians-Universität Würzburg, respectively.

On 28 August 2026, the Helmholtz Institute for One Health (HIOH) celebrated the completion of the structural shell of its new research building at the Berthold-Beitz-Platz campus together with guests from science, politics – including Bettina Martin, Minister for Science of Mecklenburg-Western Pomerania – and partner institutions. The €38 million project is jointly funded by the state of Mecklenburg-Western Pomerania, which is contributing €26.5 million, and the federal government.

Dennis Rohde, a member of the German Bundestag and Parliamentary State Secretary at the Federal Ministry of Finance (BMF), visited the Braunschweig campus of the Helmholtz Centre for Infection Research (HZI) today. He was accompanied by Braunschweig’s Mayor, Dr. Thorsten Kornblum. The visit focused on discussions with the HZI management and researchers as well as insights into key research and infrastructure areas at the HZI.